Journals / JAREM / 2021 / Cilt: 11 - Sayı: 1

Evaluation of Oral Anticoagulant Usage Satisfaction in Home Care Patients Using Warfarin

Varfarin Kullanan Evde Bakım Hastalarında Oral Antikoagülan Kullanım Memnuniyetinin Değerlendirilmesi

Journal
JAREM
Pages
38–45
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was determined that the number of additional chronic diseases and bleeding conditions while using warfarin had a significant effect on the total score and subscale scores of DASS (for total score, p=0.046; for subscale scores, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Warfarin is the most commonly used oral anticoagulant for the prevention and treatment of thromboembolic diseases.
📊
Key Findings & Data:Methods: This descriptive study was performed with patients who used warfarin and registered at the Home Health Care Services Unit of a tertiary hospital between May 2017 and November 2017.
💡
Conclusion & Impact:It was determined that the number of additional chronic diseases and bleeding conditions while using warfarin had a significant effect on the total score and subscale scores of DASS (for total score, p=0.046; for subscale scores, p
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Warfarin is the most commonly used oral anticoagulant for the prevention and treatment of thromboembolic diseases. However, the difficulty of treatment management adversely affects patient satisfaction. The objective of this study is to measure the satisfaction of using warfarin among home care patients and determine the factors affecting their satisfaction levels. Methods: This descriptive study was performed with patients who used warfarin and registered at the Home Health Care Services Unit of a tertiary hospital between May 2017 and November 2017. Importantly, the sociodemographic and clinical features of the patients were determined. Patients’ satisfaction with drug use was evaluated using the Duke Anticoagulant Satisfaction Scale (DASS). Results: The ages of 97 patients included in the study ranged from 19 to 92 years; moreover, 71.1% (n=69) of the patients were women. In total, 41.2% (n=40) of the patients have had haemorrhagic events during the use of warfarin. The DASS mean score of the patients was 57.67±14.56, 20.46±5.89 for the limitations with the treatment, 21.54±7.46 for the hassles and burdens, and 15.67±4.87 for the positive impacts. It was determined that the number of additional chronic diseases and bleeding conditions while using warfarin had a significant effect on the total score and subscale scores of DASS (for total score, p=0.046; for subscale scores, p

Özet

Amaç: Varfarin; tromboembolik hastalıkların önlenmesi ve tedavisinde en sık kullanılan oral antikoagülandır. Ancak tedavi yönetiminin zorluğu; tedaviye uyumu ve hasta memnuniyetini olumsuz etkilemektedir. Bu çalışmada; varfarin kullanan evde bakım hastalarının ilaç kullanımına bağlı memnuniyetini ölçmek ve memnuniyet düzeylerini etkileyen faktörleri saptamak amaçlanmıştır. Yöntemler: Bu çalışma; tanımlayıcı nitelikte olup Mayıs 2017-Kasım 2017 tarihleri arasında üçüncü basamak bir hastanenin evde sağlık hizmetleri birimine kayıtlı hastalardan varfarin kullananlar ile yapıldı. Hastaların sosyodemografik ve klinik özellikleri sorgulandı. İlaç kullanımına bağlı memnuniyeti değerlendirmek için Duke Antikoagülan Memnuniyet Ölçeği (DAMÖ) uygulandı. Bulgular: Çalışmaya dahil edilen 97 hastanın yaşları 19 ila 92 arasında değişmekte olup %71,1’i (n=69) kadın idi. %41,2’si (n=40) varfarin kullanırken kanama yaşamış idi. Hastaların DAMÖ puan ortalaması 57,67±14,56; kısıtlılıklar alt boyut ortalaması 20,46±5,89, yükler ve zorluklar alt boyut ortalaması 21,54±7,46, olumlu etkiler alt boyut ortalaması 15,67±4,87 saptandı. Hastaların ek kronik hastalık sayısı ve varfarin kullanırken kanama geçirme öykülerinin olmasının DAMÖ toplam puanı ve bazı alt ölçek puanlarına anlamlı düzeyde etki ettiği (toplam puan için p=0,046; p

🔖

Cite This Article

BASAT, O., KARAMAN, S. T., AKGÜN, S., ÖZDEMİR, S. (2022). Evaluation of Oral Anticoagulant Usage Satisfaction in Home Care Patients Using Warfarin. JAREM, Cilt: 11 - Sayı: 1, 38–45. https://ajindex.com/articles/558156

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Sağlık Bakanlığınca sunulan evde sağlık hizmetlerinin uygulama usul ve esasları hakkında yönerge. Son Erişim Tarihi: 01.09.2020. Erişim adresi: https://hsgm.saglik.gov.tr/dosya/mevzuat/yonergeler/evde_saglik_ hizmeti_yonerge.pdf 2. Van Walraven C, Hart RG, Connolly S, Austin PC, Mant J, Hobbs FD, et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke 2009; 40: 1410-6. 3. Grunau BE, Wiens MO, Harder KK. Patient self-management of warfarin therapy. Can Fam Physician 2011; 57: e292-8. 4. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893-962. 5. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the early management of patients with acute ıschemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018; 49: 46-99. 6. Ommaty R. Vademecum-Kardiyoloji. İstanbul: Medical Tribune Yayıncılık; 2009; 302-420. 7. Connock M, Stevens C, Fry-Smith A, Jowett S, Fitzmaurice D, Moore D, et al. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technol Assess 2007; 11: iii-iv, ix-66. doi: 10.3310/hta11380. 8. Elewa HF, DeRemer CE, Keller K, Gujral J, Joshua TV. Patients satisfaction with warfarin and willingness to switch to dabigatran: a patient survey. J Thromb Thrombolysis 2014; 38: 115-20. 9. Wang Y, Kong MC, Lee LH, Ng HJ, Ko Y. Knowledge, satisfaction, and concerns regarding warfarin therapy and their association with warfarin adherence and anticoagulation control. Thromb Res 2014; 133: 550-4. 10. Köksal AT, Avşar G. What patients taking oral anticoagulants know and do about anticoagulant therapy: evaluation of patients in a cardiology service. Balikesir Saglik Bil Derg 2015; 4: 137-42. 11. Briggs AL, Jackson TR, Bruce S, Shapiro NL. The development and performance validation of a tool to assess patient anticoagulation knowledge. Res Social Adm Pharm 2005; 1: 40-59. 12. Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM. Warfarin use in the elderly: the nurses’ perspective. Aust J Adv Nurs 2006; 23: 19-25. 13. Yıldırım JG, Bayık-Temel A. The validity and reliability of Turkish version of the Duke anticoagulation